-
Perspectives for the clinical application of ctDNA analysis to breast cancer drug therapy Breast Cancer (IF 4.0) Pub Date : 2024-04-23 Tetsuhiro Yoshinami
-
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors Breast Cancer (IF 4.0) Pub Date : 2024-04-23 Pei-Jing Yang, Eing-Mei Tsai, Ming-Feng Hou, Yen-Jung Lee, Tsu-Nai Wang
-
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database Breast Cancer (IF 4.0) Pub Date : 2024-04-21 Yuhang Shang, Xuelian Wang, Yansong Liu, Weilun Cheng, Yunqiang Duan, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Ting Wang, Tianshui Yu, Anbang Hu, Jiarui Zhang, Hanyu Zhang, Mingcui Li, Zhiyuan Rong, Yanling Li, Suborna S. Shakila, Xinxin Li, Jianyuan Feng, Fei Ma, Baoliang Guo
-
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status Breast Cancer (IF 4.0) Pub Date : 2024-04-21 Sei Na, Milim Kim, Yujun Park, Hyun Jung Kwon, Hee-Chul Shin, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, So Yeon Park
-
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study Breast Cancer (IF 4.0) Pub Date : 2024-04-20 Tetsuhiro Yoshinami, Shigenori E. Nagai, Masaya Hattori, Takuho Okamura, Kenichi Watanabe, Takahiro Nakayama, Hiroko Masuda, Michiko Tsuneizumi, Daisuke Takabatake, Michiko Harao, Hiroshi Yoshino, Natsuko Mori, Hiroyuki Yasojima, Chiya Oshiro, Madoka Iwase, Miki Yamaguchi, Takafumi Sangai, Nobuyoshi Kosaka, Kentaro Tajima, Norikazu Masuda
-
French national survey on breast cancer care: caregiver and patient views Breast Cancer (IF 4.0) Pub Date : 2024-04-18 Christine Rousset-Jablonski, Barbara Lortal, Sophie Lantheaume, Laurent Arnould, Hélène Simon, Anne-Sophie Tuszynski, Mélanie Courtier, Soukayna Debbah, Marc Lefrançois, Sita Balbin, Anne-Sophie Kably, Alain Toledano
-
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-04-17 Huan-ping Zhang, Rui-yuan Jiang, Jia-yu Zhu, Ke-na Sun, Yuan Huang, Huan-huan Zhou, Ya-bing Zheng, Xiao-jia Wang
-
The usefulness of artificial intelligence in breast reconstruction: a systematic review Breast Cancer (IF 4.0) Pub Date : 2024-04-15 Karla C. Maita, Francisco R. Avila, Ricardo A. Torres-Guzman, John P. Garcia, Gioacchino D. De Sario Velasquez, Sahar Borna, Sally A. Brown, Clifton R. Haider, Olivia S. Ho, Antonio Jorge Forte
-
Inter- and intra-observer variability of qualitative visual breast-composition assessment in mammography among Japanese physicians: a first multi-institutional observer performance study in Japan Breast Cancer (IF 4.0) Pub Date : 2024-04-15 Yoichi Koyama, Kazuaki Nakashima, Shunichiro Orihara, Hiroko Tsunoda, Fuyo Kimura, Natsuki Uenaka, Kanako Ban, Yukiko Michishita, Yoshihide Kanemaki, Arisa Kurihara, Kanae Tawaraya, Masataka Taguri, Takashi Ishikawa, Takayoshi Uematsu
-
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study Breast Cancer (IF 4.0) Pub Date : 2024-04-12 Peter J. K. Tokuda, Takamasa Mitsuyoshi, Yuka Ono, Takahiro Kishi, Yoshiharu Negoro, Setsuko Okumura, Itaru Ikeda, Takashi Sakamoto, Yumi Kokubo, Ryo Ashida, Toshiyuki Imagumbai, Mikiko Yamashita, Hiroaki Tanabe, Sayaka Takebe, Mariko Tokiwa, Eiji Suzuki, Chikako Yamauchi, Michio Yoshimura, Takashi Mizowaki, Masaki Kokubo
-
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases Breast Cancer (IF 4.0) Pub Date : 2024-04-10 Alexandre De Moura, Delphine Loirat, Sarah Vaillant, Sinen Korbi, Nicolas Kiavue, Diana Bello Roufai, Laurence Escalup, Romain Desmaris, Pauline Vaflard, Paul Cottu, Jean-Yves Pierga, François-Clément Bidard, Luc Cabel, Alexandre Acramel
-
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis Breast Cancer (IF 4.0) Pub Date : 2024-04-09 Katsuyoshi Suzuki, Shinichiro Morishita, Jiro Nakano, Taro Okayama, Junichiro Inoue, Takashi Tanaka, Takuya Fukushima
-
Nipple–areolar complex malposition in breast reconstruction after nipple-sparing mastectomy: a multi-institutional retrospective observational study in Japan Breast Cancer (IF 4.0) Pub Date : 2024-04-08 Sayuri Kato, Hiroki Mori, Miho Saiga, Satoko Watanabe, Shinsuke Sasada, Ayano Sasaki, Akiko Ogiya, Mao Yamamoto, Kazutaka Narui, Junji Takano, Hirohito Seki, Naomi Nagura, Makoto Ishitobi, Tadahiko Shien
-
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues Breast Cancer (IF 4.0) Pub Date : 2024-04-08 Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
-
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap Breast Cancer (IF 4.0) Pub Date : 2024-04-06 Joep A. F. van Rooij, Ennie Bijkerk, René R. J. W. van der Hulst, Stefania M. H. Tuinder
-
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2024-04-05 Michio Yoshimura, Chikako Yamauchi, Naoko Sanuki, Yasushi Hamamoto, Kimiko Hirata, Jiro Kawamori, Mariko Kawamura, Mami Ogita, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
The Breast Cancer Clinical Practice Guidelines, organized by the Japanese Breast Cancer Society (JBCS), were published in 2022. We present the English version of the Radiation Therapy (RT) section of the guidelines. The JBCS formed a task force to update the 2018 version of the JBCS Clinical Practice Guidelines. The Background Questions (BQs) contain the standard treatments for breast cancer in clinical
-
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy Breast Cancer (IF 4.0) Pub Date : 2024-04-04 Hiroko Nogi, Akiko Ogiya, Makoto Ishitobi, Chikako Yamauchi, Hiroki Mori, Ayaka Shimo, Kazutaka Narui, Naomi Nagura, Hirohito Seki, Shinsuke Sasada, Teruhisa Sakurai, Tadahiko Shien
Background In breast cancer patients receiving neoadjuvant chemotherapy (NAC), immediate breast reconstruction (IBR) as a breast cancer treatment option remains controversial. We assessed the impact of NAC on surgical and oncological outcomes of patients undergoing IBR. Methods This was a retrospective multicenter study of 4726 breast cancer cases undergoing IBR. The rate of postoperative complications
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Breast Cancer (IF 4.0) Pub Date : 2024-04-03
Abstract The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition was published in June 2022. The guidelines were prepared while conforming as much as possible to the “Minds Manual for Guideline Development 2020 ver. 3.0.” edited by the Minds Manual Development Committee of the Japan Council for Quality Health Care in 2021. In addition, a survey of Japanese Breast
-
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy Breast Cancer (IF 4.0) Pub Date : 2024-04-02 Dan Lin, Kathleen M. Sturgeon, Joshua E. Muscat, Shouhao Zhou, Andrea L. Hobkirk, Katie M. O’Brien, Dale P. Sandler, Cheryl L. Thompson
Purpose Higher pre-diagnosis physical activity (PA) is associated with lower all-cause mortality in breast cancer (BCa) patients. However, the association with pathological complete response (pCR) is unclear. We investigated the association between pre-diagnosis PA level and chemotherapy completion, dose delay, and pCR in BCa patients receiving neoadjuvant chemotherapy (NACT). Methods 180 stage I–III
-
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-04-01 Jin-hui Ye, Jian Yu, Ming-ying Huang, Yue-mei Mo
Background Patients with breast cancer (BC) at advanced stages have poor outcomes because of high rate of recurrence and metastasis. Biomarkers for predicting prognosis remain to be explored. This study aimed to evaluate the relationships between circulating tumor cells (CTCs) and outcomes of BC patients. Patients and methods A total of 50 female were enrolled in this study. Their diagnoses were determined
-
Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-30
Abstract Among the analytes circulating in body fluids, microRNAs, a type of non-coding RNA and known to exist 2655 in primates, have attracted attention as a novel biomarker for cancer screening. MicroRNAs are signaling molecules with important gene expression regulatory functions that can simultaneously control many gene functions and multiple different pathways in living organisms. These microRNAs
-
-
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management Breast Cancer (IF 4.0) Pub Date : 2024-03-21 Kazuki Hashimoto, Takahiro Ochiya, Akihiko Shimomura
This article examines liquid biopsy using non-coding RNAs and extracellular vesicles in detail. Liquid biopsy is emerging as a prominent non-invasive diagnostic tool in the treatment of breast cancer. We will elucidate the roles of these molecules in early detection, monitoring treatment effectiveness, and prognostic assessment of breast cancer. Additionally, the clinical significance of these molecules
-
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-21 Kazutaka Narui, Toshihiko Satake, Takashi Ishikawa, Mayu Muto, Yui Tsunoda, Akimitsu Yamada, Kei Kawashima, Natsuki Uenaka, Yoshie Fujiwara, Masanori Oshi, Shoko Adachi, Chiho Suzuki, Tomoko Wada, Shinya Yamamoto, Mikiko Tanabe, Jiro Maegawa, Itaru Endo
-
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-20 Kim Vo, Colton Ladbury, Stephanie Yoon, Jose Bazan, Scott Glaser, Arya Amini
-
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances Breast Cancer (IF 4.0) Pub Date : 2024-03-16
Abstract Liquid biopsy using circulating tumor DNA (ctDNA) has been reported to be less invasive and effective for comprehensive genetic analysis of heterogeneous solid tumors, including decision-making for therapeutic strategies, predicting recurrence, and detecting genetic factors related to treatment resistance in various types of cancers. Breast cancer, colorectal cancer, and lung cancer are among
-
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-14 Xue Hu
-
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB Breast Cancer (IF 4.0) Pub Date : 2024-03-12 Guo Li, Xinyue Lin, Xinpeng Wang, Lvjuan Cai, Jianren Liu, Yunyun Zhu, Zhichao Fu
-
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Breast Cancer (IF 4.0) Pub Date : 2024-03-12 Danbee Kang, Seri Park, Hyo Jung Kim, Jiseon Lee, Jiyoon Han, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park
Background In recognition of the distinct clinical challenges and research gaps in young breast cancer (YBC) patients, we established the Comprehensive Young Age Breast Cancer (CHARM) registry to collect prospective data. Methods This prospective cohort included patients who were newly diagnosed with histologically confirmed breast cancer without prior treatment at the Samsung Medical Center (SMC)
-
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-08
Abstract Background Characteristics of taxane-induced peripheral neuropathy (PN) could be different between paclitaxel and nab-paclitaxel. The purpose of this prospective observational multicenter cohort study was to compare tri-weekly nab-paclitaxel to weekly standard paclitaxel regarding the severity, onset and recovery of sensory and motor PN in patients with breast cancer. Methods Patients with
-
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Breast Cancer (IF 4.0) Pub Date : 2024-03-07 Yasue Tsuchida, Naoki Niikura, Takashi Chishima, Mari Mizuno, Takahiko Kawate, Hiromi Fuchikami, Yasuo Miyoshi, Takehiko Sakai, Haruru Kotani, Naoto Kondo, Naoki Hayashi
-
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis Breast Cancer (IF 4.0) Pub Date : 2024-03-07 Ken Oba, Maki Adachi, Tomoya Kobayashi, Eichi Takaya, Daiki Shimokawa, Toshinori Fukuda, Kengo Takahashi, Kazuyo Yagishita, Takuya Ueda, Hiroko Tsunoda
-
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Breast Cancer (IF 4.0) Pub Date : 2024-03-04 Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi, Eri Ishikawa, Seiichi Hirota, Yasuo Miyoshi
-
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Breast Cancer (IF 4.0) Pub Date : 2024-03-04 Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, Junji Tsurutani, Toshimi Takano, Shigehira Saji, Shinobu Masuda, Rie Horii, Hitoshi Tsuda, Rin Yamaguchi, Tatsuya Toyama, Chikako Yamauchi, Masakazu Toi, Yutaka Yamamoto
The Japanese Breast Cancer Society Clinical Practice Guidelines are published as timely guidance on clinical issues in breast cancer treatment in Japan. In the recent edition of these guidelines, we addressed a new clinical question 34 (CQ 34, systemic treatment part) “Is trastuzumab deruxtecan recommended for patients with unresectable or metastatic HER2-low breast cancer?” and a new future research
-
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β Breast Cancer (IF 4.0) Pub Date : 2024-02-29 Monalisa Parija, Surya Prakash, B. Madhu Krishna, Sanghamitra Dash, Sandip K. Mishra
-
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Breast Cancer (IF 4.0) Pub Date : 2024-02-18 Nalee Kim, Won Kyung Cho, Won Park, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Eun Sook Ko, Haeyoung Kim
-
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-15 Kazuhiko Sato, Hiromi Fuchikami, Naoko Takeda, Nana Natsume, Masahiro Kato
-
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-13 Sean M. Hacking, Gabrielle Windsor, Robert Cooper, Zhicheng Jiao, Ana Lourenco, Yihong Wang
-
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy Breast Cancer (IF 4.0) Pub Date : 2024-02-07 Mikiko Kasahara, Sayaka Kanematsu, Yoshihito Tanaka, Satoshi Okazaki, Masahiro Watatani
-
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry Breast Cancer (IF 4.0) Pub Date : 2024-02-06 Takayuki Iwamoto, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Minoru Miyashita, Takaaki Konishi, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
-
Advances in the study of autophagy in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-05 Tang Yu, Liu Rui, Zhao Jiumei, Li Ziwei, Hu Ying
-
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-04
Abstract Background Long non-coding RNAs (lncRNAs) have been found to play important roles in occurrence, development, and metastasis of various tumors. We aimed to screen long non-coding RNAs (lncRNAs) that promote invasion and metastasis of breast cancer cells under hypoxia, and investigate the relationship between lncRNA expression and clinicopathological features and prognosis in invasive breast
-
Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study Breast Cancer (IF 4.0) Pub Date : 2024-02-02
Abstract Background Although there is increasing interest in minimally invasive prosthesis breast reconstruction (PBR), whether meshes application in minimally invasive PBR can improve complications and cosmetic effects remains controversial. The author retrospectively analyzed postoperative complications and evaluated patient-reported quality-of-life outcomes in minimally invasive PBR with and without
-
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models Breast Cancer (IF 4.0) Pub Date : 2024-01-30 Hongyan Zheng, Lihua Wu, Jianfeng Chen, Na Na, Ge Lou
-
Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-01-24
Abstract Background γ1-Adaptin is a subunit of adaptor protein complex-1 (AP-1), which regulates intracellular transport between the trans-Golgi network (TGN) and endosomes. Since expression levels of AP-1 subunits have been reported to be associated with cell proliferation and cancer malignancy, we investigated the relationships between the immunohistochemical expression of γ1-adaptin and both clinicopathological
-
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes Breast Cancer (IF 4.0) Pub Date : 2024-01-17 Wu Ding, Dengfeng Ye, Haifeng Chen, Yingli Lin, Zhian Li, Chuanjian Tu
-
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan Breast Cancer (IF 4.0) Pub Date : 2024-01-05 Yasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, Minoru Miyashita, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Naoko Kinukawa, Chie Watanabe, Masakazu Toi, Shigehira Saji
-
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy Breast Cancer (IF 4.0) Pub Date : 2024-01-04 Naruto Taira, Yuichiro Kikawa, Takayuki Iwamoto, Yuichiro Miyoshi, Kyoko Hara, Seiji Yoshitomi, Hajime Hikino, Hirotoshi Takahashi, Daisuke Takabatake, Shinichiro Kubo, Masahiko Ikeda, Hiroyoshi Doihara, Tadahiko Shien, Hiromi Okuyama, Yuko Tanabe, Fumikata Hara, Kosho Yamanouchi, Yasuhiro Hagiwara, Masataka Sawaki
-
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole Breast Cancer (IF 4.0) Pub Date : 2024-01-01 Masato Takahashi, Tomofumi Osako, Hiroyuki Yasojima, Kenichi Inoue, Masahiro Kawashima, Hideki Maeda, Akemi Ichikawa, Yasuaki Muramatsu, Norikazu Masuda
-
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience Breast Cancer (IF 4.0) Pub Date : 2023-12-27 Yi-Wen Hong, I-Ming Kuo, Wen-Ling Kuo, Chi-Chang Yu, Shih-Che Shen, Hsiu-Pei Tsai, Chia-Hui Chu, Hui-Yu Ho, Yung-Feng Lo, Shin-Cheh Chen, Yung-Chang Lin, Chih-Ying Chien, Hsu-Huan Chou
-
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2023-12-26 Masaaki Kawai, Shoichiro Ohtani, Motoki Iwasaki, Seiichiro Yamamoto, Kiyoshi Takamatsu, Hitoshi Okamura, Masami Arai, Tsunehisa Nomura, Shinji Ozaki, Ken-ichi Shibata, Ayaka Akabane, Fuyuhiko Motoi, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
-
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Breast Cancer (IF 4.0) Pub Date : 2023-12-26 Han Hsi Wong, Elena Cojocaru, James Watkins, Sujil James, Tony Aloysius, Jennifer Harrington, Gail Horan, Helen Hatcher
-
Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence Breast Cancer (IF 4.0) Pub Date : 2023-12-22
Abstract Background Metastatic spread is characterized by considerable heterogeneity in most cancers. With increasing treatment options for patients with metastatic disease, there is a need for insight into metastatic patterns of spread in breast cancer patients using large-scale studies. Methods Records of 2622 metastatic breast cancer patients who underwent autopsy (1974–2010) were retrieved from
-
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale Breast Cancer (IF 4.0) Pub Date : 2023-12-11 Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura, Chikako Shimizu, Tomoko Taniyama, Manami Tada, Nao Yoshida, Hitomi Sato, Kiyomi Nonogaki, Kazumasa Yamamoto, Taro Yamanaka, Rika Kizawa, Takeshi Yamaguchi, Kiyo Tanaka, Yoko Kobayashi, Nobuko Tamura, Yuko Tanabe, Yuji Miura, Yuichiro Kikawa, Juhee Cho, Hidetaka Kawabata
-
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan Breast Cancer (IF 4.0) Pub Date : 2023-12-09 Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I. Lai, Ling-Ming Tseng, Chi-Cheng Huang
-
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database Breast Cancer (IF 4.0) Pub Date : 2023-12-03 Zhenning Tang, Ling Li, Xiaoying Huang, Yinbing Zhao, Lingyan Huang
-
Annual report of the Japanese Breast Cancer Registry for 2019 Breast Cancer (IF 4.0) Pub Date : 2023-12-04 Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
-
The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening Breast Cancer (IF 4.0) Pub Date : 2023-11-28 Akira Nakamura, Koji Ohnuki, Haruka Takahashi, Shin Usami, Yuki Ishida, Setsuko Shibata, Akiko Umemura, Yuka Takikawa, Atsushi Kano
Objective Various efforts have been made to improve the accuracy of breast cancer screening. This study aimed to report differences in the contribution of ultrasonography to cancer screening assessments of dense and non-dense breasts. Methods The participants in this study were 29,640 Japanese women in their 40 s who underwent breast cancer screening at the Iwate Cancer Society between 2018 and 2021
-
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-11-23 Asumi Iesato, Atsushi Fushimi, Rie Tahara, Mitsuo Terada, Madoka Iwase, Chihiro Kawamura, Nami Yamashita
-
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan Breast Cancer (IF 4.0) Pub Date : 2023-11-20 Yoshitaka Nishikawa, Nobukazu Agatsuma, Takahiro Utsumi, Taro Funakoshi, Yukiko Mori, Yuki Nakamura, Nobuaki Hoshino, Takahiro Horimatsu, Takumi Saito, Soichiro Kashihara, Jun Fukuyoshi, Rei Goto, Masakazu Toi, Yoshimitsu Takahashi, Takeo Nakayama